Notable Facts
→CFO and COO of publicly traded Liquidia Corporation (NASDAQ: LQDA) since 2020
→Board member of three companies: Alimera Sciences (NASDAQ: ALIM), Bryn Pharma, and Heron Therapeutics (NASDAQ: HRTX)
→Previously CFO at Sanofi North America managing a $10 billion business
→Age 48, holds BBA in Accounting from James Madison University, CPA licensed in New Jersey
→Extensive biotech and pharmaceutical experience across multiple senior finance roles
→Recent promotion to dual CFO/COO role in January 2024 at Liquidia